Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

BMRN BioMarin Pharmaceutical Inc

66,03

0,61 (0,93%)

29 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more BioMarin Pharmaceutical Charts.

BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more BioMarin Pharmaceutical Charts.

News BioMarin Pharmaceutical Inc

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
Samstag 16 November 2024 (2 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

BioMarin to Participate in Three Upcoming Investor Conferences
Mittwoch 6 November 2024 (3 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 31 Oktober 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 29 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
Dienstag 29 Oktober 2024 (1 Monat vor) • PR Newswire (US)

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
Donnerstag 24 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.

BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET
Mittwoch 16 Oktober 2024 (1 Monat vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 1 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 1 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Montag 30 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere BioMarin Pharmaceutical Inc News-Artikel

JP Morgan Chase

Financial Select Sector

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Deutsche Telekom

Euro vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen